Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

The list of trillion-dollar stocks is small and doesn't feature a single medical company. That might change in the next decade, as several leading healthcare stocks have market caps that are inching closer to that milestone. AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Abbott Laboratories (NYSE: ABT) are among the largest.These healthcare leaders are well-established dividend payers -- all three are in the exclusive group of Dividend Kings that have increased their dividend for at least 50 years -- but can they deliver the kinds of returns they need through the next decade to hit a $1 trillion valuation? Let's find out.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool